These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18034763)

  • 21. Duration of anticoagulation after venous thrombosis.
    Eichinger S; Kyrle PA
    Vasa; 2012 Jan; 41(1):11-7. PubMed ID: 22247055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Great Debates in Vascular Medicine: Extended duration anticoagulation for unprovoked venous thromboembolism - Coming to consensus when the debate rages on.
    Kanthi Y; Piazza G
    Vasc Med; 2018 Aug; 23(4):384-387. PubMed ID: 29734862
    [No Abstract]   [Full Text] [Related]  

  • 25. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
    Zabczyk M; Plens K; Wojtowicz W; Undas A
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients.
    Haas S; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Dalsgaard Nielsen J; Kayani G; Zaghdoun A; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK
    J Thromb Haemost; 2019 Oct; 17(10):1694-1706. PubMed ID: 31220403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-Based Therapies for Pharmacologic Prevention and Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism.
    Jacobs B; Henke PK
    Surg Clin North Am; 2018 Apr; 98(2):239-253. PubMed ID: 29502769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of venous thromboembolism in patients with cancer.
    López-Núñez JJ; Trujillo-Santos J; Monreal M
    J Thromb Haemost; 2018 Dec; 16(12):2391-2396. PubMed ID: 30246407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are we ready to start outpatient treatment for pulmonary embolism?
    Meyer G
    Thromb Haemost; 2008 Nov; 100(5):736-7. PubMed ID: 18989512
    [No Abstract]   [Full Text] [Related]  

  • 31. Venous thromboembolism: diagnosis and current anticoagulation strategies for deep vein thrombosis and pulmonary embolism.
    Pascarella L; Cox MW; O'Brien PJ
    Hosp Pract (1995); 2012 Aug; 40(3):58-70. PubMed ID: 23086095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended oral anticoagulant therapy after a first episode of pulmonary embolism.
    Agnelli G; Prandoni P; Becattini C; Silingardi M; Taliani MR; Miccio M; Imberti D; Poggio R; Ageno W; Pogliani E; Porro F; Zonzin P;
    Ann Intern Med; 2003 Jul; 139(1):19-25. PubMed ID: 12834314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism.
    Monahan M; Ensor J; Moore D; Fitzmaurice D; Jowett S
    J Thromb Haemost; 2017 Aug; 15(8):1591-1600. PubMed ID: 28520199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of venous thromboembolism.
    Burnett B
    Prim Care; 2013 Mar; 40(1):73-90. PubMed ID: 23402462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry.
    Cohen AT; Gitt AK; Bauersachs R; Fronk EM; Laeis P; Mismetti P; Monreal M; Willich SN; Bramlage P; Agnelli G; Prefer In Vte Scientific Steering Committee And The Prefer In Vte Investigators OBOT
    Thromb Haemost; 2017 Jun; 117(7):1326-1337. PubMed ID: 28405675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism in pregnancy.
    James AH
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):326-31. PubMed ID: 19228606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What NPs need to know about anticoagulation therapy.
    Gay SE; Munaco S
    Nurse Pract; 2012 Oct; 37(10):28-34. PubMed ID: 23014177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The optimal duration of anticoagulation in patients with venous thromboembolism: how long is long enough?
    Prandoni P; Piovella C; Spiezia L; Dalla Valle F; Pesavento R
    Panminerva Med; 2012 Mar; 54(1):39-44. PubMed ID: 22278115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of warfarin in pulmonary embolism.
    Miller A; Campbell I; Fennerty T; Raskob GE; Büller HR
    Chest; 2006 Jul; 130(1):299; author reply 299-300. PubMed ID: 16840417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.